Nadav Kidron, CEO and director of Oramed Pharmaceuticals, discusses his company’s medical breakthrough in adapting insulin so that it can be taken as a pill instead of a shot. Can this technology be used for other kinds of medication? What does this mean for modern medicine?
Share this article on WhatsApp:
Advertisement
SHARE
Previous articlePresident Rivlin Tells Arab Media Ramadan Based on ‘Compassion’
Next articleIt’s Q Time!
Doug Goldstein, CFP®
http://www.profile-financial.com
Douglas Goldstein, CFP®, is the director of Profile Investment Services, Ltd, a financial planning and investment services firm specializing in working with Americans living in Israel who have investment accounts in America. He is a licensed financial professional both in the U.S. and Israel.